Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260417006) titled 'Treatment Outcomes of Non-Small Cell Lung Cancer Adenocarcinoma in Locally Advanced and Metastatic Stages Following EGFR Mutation Testing from Tissue or Plasma Samples' on April 17.
Study Type: Observational
Primary Sponsor: Phrapokklao Hospital
Condition:
Duration of EGFR mutation testing in non small cell carcinoma
Treatment covered in EGFR mutated NSCLC with EGFR TKI treatment
Survival and progression free survival time in EGFR mutated/non mutated Group
Lung cancer
EGFR Mutation
Targeted therapy
Laboratory management
Lean process
Lung cancer
EGFR Mutation
Targeted therapy
Laboratory management
Lean proces...